Cigna Corp. (CI) Misses Q2 EPS Views; Updates FY16 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on Alphabet boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Leerink Partners Cuts Price Target on Cigna Corp. (CI) to $155 Following 2Q Miss
August 1, 2016 10:10 AM EDTLeerink Partners maintained an Outperform rating on CIGNA (NYSE: CI), and cut the price target to $155.00 (from $160.00), following the company's 2Q earnings report. The company reported an EPS miss of 39c and $1.20 guide-down driven mostly by Group Life & Disability but to a lesser extent Global Healthcare.
Analyst Ana Gupte commented, "We revise our CI 2017E and 2018E EPS to $9.50 & $10.88 after a surprise miss and guide-down on Disability & Life as well as a smaller miss in Healthcare. The miss in... More
